Zynex, Inc. (ZYXIQ)
OTCMKTS · Delayed Price · Currency is USD
0.0870
+0.0167 (23.76%)
At close: Jan 16, 2026
Zynex Market Cap
Zynex has a market cap or net worth of $2.68 million as of January 16, 2026. Its market cap has decreased by -98.94% in one year.
Market Cap
2.68M
Enterprise Value
61.04M
Revenue
108.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since May 24, 2004, Zynex's market cap has decreased from 59.18M to 2.68M, a decrease of -95.47%. That is a compound annual growth rate of -13.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 2.16M | -43.49% |
| Dec 31, 2025 | 3.83M | -98.50% |
| Dec 31, 2024 | 255.08M | -30.91% |
| Dec 29, 2023 | 369.21M | -29.13% |
| Dec 30, 2022 | 520.98M | 48.42% |
| Dec 31, 2021 | 351.01M | -25.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 811.81M |
| Glass House Brands | 738.79M |
| Elite Pharmaceuticals | 515.71M |
| Northwest Biotherapeutics | 440.23M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 338.88M |
| Silence Therapeutics | 277.26M |